Since its inception in 2017, the American Oncology Network, LLC (AON) has participated in the Oncology Care Model (OCM), a national innovative payment program of the Center for Medicare & Medicaid Innovation (CMMI).
FORT MYERS, FLA., November 25, 2019 — Since its inception in 2017, the American Oncology Network, LLC (AON) has participated in the Oncology Care Model (OCM), a national innovative payment program of the Center for Medicare & Medicaid Innovation (CMMI). Through its participation in OCM, AON’s affiliated practices are providing high-quality enhanced services to Medicare beneficiaries, such as care coordination, navigation, and national treatment guidelines, while reducing the cost of cancer care through payment arrangements that include financial and performance accountability.
Based on its record of success in community oncology practices across the nation, AON is expanding its participation in the program by choosing to adopt an alternative “2-sided risk” model that would create additional savings for patients and, potentially, for its affiliated practices. In the new 2-sided risk model, providers still share in savings, if spending is below the benchmark, as they do in the previous 1-sided risk model; however, under the 2-sided model, providers also are responsible for some of the loss if spending is above the benchmark.
Brad Prechtl, MBA, CEO of AON, said, “AON’s affiliated practices are community oncology practices that provide extremely high-quality care. Being part of the American Oncology Network allows these practices to provide enhanced services to their patients, such as an in-house specialty pharmacy, world-class pathology lab and national clinical research, as well as the ability to participate in the Oncology Care Model, which, in turn, provides added benefits to patients in their local community.”
For more information, see the full press release here.